Product Information
NYSTATIN-TRIAMCINOLONE OINTMENT is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.2354 per GM under NDC 62332058560. Its NADAC has been published 217 times since Aug 10, 2022.
FDA first approved this application on Mar 4, 2022. Its Orange Book therapeutic-equivalence code is AT.
Strength
100000; 1 [USP'U]/g; mg/g
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332058560
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
NYSTATIN; TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214186FDA Approved
3/4/2022
TE Code
AT
On Market Since
3/15/2022
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN-TRIAMCINOLONE OINTMENT has been published 217 times since Aug 10, 2022, and over the history we have for it it has declined 28.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2354 per GM |
|---|---|
| All-time high | $0.3285 (Aug 10, 2022) |
| All-time low | $0.1662 (Jan 18, 2023) |
| 52-week high | $0.2479 |
| 52-week low | $0.2058 |
| Median price | $0.2316 |
| Average price | $0.2315 |
| Largest weekly change | +73.9% (Mar 20, 2024) |
| Weeks tracked | 217 |
| Tracking since | Aug 10, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nystatin and Triamcinolone Acetonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NYSTATIN-TRIAMCINOLONE OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN-TRIAMCINOLONE OINTMENT, manufactured by Alembic Pharmaceuticals Inc., is $0.2354 per GM (NDC 62332058560), effective Sep 30, 2026.
How has the price of NYSTATIN-TRIAMCINOLONE OINTMENT changed over time?
Over the history we have for it, the NADAC for NYSTATIN-TRIAMCINOLONE OINTMENT has declined 28.3%. It has been tracked across 217 weekly CMS publications since Aug 10, 2022.
What are the highest and lowest recorded NADAC prices for NYSTATIN-TRIAMCINOLONE OINTMENT?
Since Aug 10, 2022, the NADAC for NYSTATIN-TRIAMCINOLONE OINTMENT has ranged from a low of $0.1662 (Jan 18, 2023) to a high of $0.3285 (Aug 10, 2022), with a median of $0.2316 per GM.
Are there cheaper alternatives to NYSTATIN-TRIAMCINOLONE OINTMENT?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN-TRIAMCINOLONE OINTM, is $0.1910 per GM — about 19% below NYSTATIN-TRIAMCINOLONE OINTMENT.
Who manufactures NYSTATIN-TRIAMCINOLONE OINTMENT?
NYSTATIN-TRIAMCINOLONE OINTMENT (NDC 62332058560) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.